Noble Life Sciences Animal Facility Awarded Full AAALAC Accreditation
News Nov 01, 2013
Noble Life Sciences has announced that its animal facility was awarded full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC International).
AAALAC assessment and accreditation programs are designed to recognize organizations that demonstrate excellence in animal care and use.
Organizations volunteer to participate in AAALAC's program in addition to complying with local, state and federal laws that regulate use of animals in research.
Accreditation was awarded following submission of a detailed program description and an in-depth review of the program and facility during an on-site visit by AAALAC representatives.
In addition, Noble is currently licensed by the United States Department Of Agriculture (USDA) and meets the assurance requirements of the National Institutes of Health’s Office of Laboratory Animal Welfare (OLAW).
Alain Cappeluti, President of Noble Life Sciences, commented: “We are pleased to receive unanimous approval from AAALAC International for full accreditation with no additional recommendations for improvement. Accreditation recognizes our commitment to exceed international standards with the highest level of animal care and research practices. It also demonstrates our dedication to providing our clients with superior resources and services to advance their preclinical research programs.”
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018